{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:51:46Z","timestamp":1785873106469,"version":"3.56.0"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Congenital disorders of glycosylation (CDG) are a heterogeneous group of inborn errors of metabolism caused by impaired protein glycosylation. Among these, PMM2-CDG, caused by defective phosphomannomutase 2 activity and affecting protein N-glycosylation, is the most prevalent. As glycoproteins are involved in almost every physiological process, the clinical manifestations in PMM2-CDG are diverse and multisystemic. In the endocrine system, glycoproteins are present in every axis, acting as hormones, prohormones, receptors, enzymes, and transport proteins. Hypoglycosylation can alter hormonal function on multiple levels. As a result, endocrinopathies are frequently part of the clinical spectrum of PMM2-CDG, particularly hypergonadotrophic hypogonadism and pubertal abnormalities in female patients. Symptoms of endocrine involvement, especially hyperinsulinemic hypoglycemia and failure to thrive during infancy, can be the presenting sign of the disease. The clinical spectrum of PMM2-CDG endocrinopathy is variable; for example, thyroid involvement can range from isolated transitory hyperthyrotropinemia to clinical hypothyroidism. Some endocrine abnormalities, such as adrenal insufficiency, are uncommon and probably underdiagnosed in PMM2-CDG. The new insights into the role of N-glycosylation on the endocrine system over the past twenty years have deepened our understanding of this complex disorder and should enable us to improve and personalize the clinical management of these patients.<\/jats:p>","DOI":"10.3389\/fendo.2025.1594118","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T04:13:37Z","timestamp":1753244017000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Phosphomannomutase 2-congenital disorder of glycosylation: exploring the role of N-glycosylation on the endocrine axes"],"prefix":"10.3389","volume":"16","author":[{"given":"Giulia","family":"Del Medico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Procopio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giosu\u00e8","family":"Annibalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Guerrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Morrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Stagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/JIMD.12024","article-title":"International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up","volume":"42","author":"Altassan","year":"2019","journal-title":"J Inherit Metab Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/PMIC.201200333","article-title":"Characterization of disease-associated N-linked glycoproteins","volume":"13","author":"Tian","year":"2013","journal-title":"Proteomics"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/GENES12111658","article-title":"Genotype-phenotype correlations in pmm2-cdg","volume":"12","author":"Vaes","year":"2021","journal-title":"Genes (Basel)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJMG.2017.10.012","article-title":"Congenital disorders of glycosylation (CDG): Quo vadis","volume":"61","author":"P\u00e9anne","year":"2018","journal-title":"Eur J Med Genet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2023.101027","article-title":"Neurological manifestations in PMM2-congenital disorders of glycosylation (PMM2-CDG): Insights into clinico-radiological characteristics, recommendations for follow-up, and future directions","volume":"26","author":"Muthusamy","year":"2024","journal-title":"Genet Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/JMEDGENET-2017-104903","article-title":"Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature","volume":"54","author":"Schiff","year":"2017","journal-title":"J Med Genet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/CHILDREN8100852","article-title":"Anthropometric phenotype of patients with pmm2-cdg","volume":"8","author":"Lipi\u0144ski","year":"2021","journal-title":"Children"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1023\/A:1021883605280","article-title":"New disorders in carbohydrate metabolism: Congenital disorders of glycosylation and their impact on the endocrine system","volume":"4","author":"Miller","year":"2003","journal-title":"Rev Endocr Metab Disord"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/S13023-014-0207-4","article-title":"29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype","volume":"9","author":"Monin","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/J.1365-2265.2009.03531.X","article-title":"IGF system in children with congenital disorders of glycosylation","volume":"70","author":"Miller","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/S00018-022-04180-X","article-title":"Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation","volume":"79","author":"Di Patria","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27233-3","article-title":"The intrinsically disordered E-domains regulate the IGF-1 prohormones stability, subcellular localisation and secretion","volume":"8","author":"Annibalini","year":"2018","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/B978-012088484-1\/50006-9","article-title":"Mechanisms of signal transduction utilized by growth hormone","volume-title":"The Somatotrophic Axis in Brain Function","author":"Shafiei","year":"2006"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ghir.2005.11.001","article-title":"Physiology and pathophysiology of growth hormone-binding protein: Methodological and clinical aspects","volume":"16","author":"Fisker","year":"2006","journal-title":"Growth Hormone IGF Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/ADC.85.3.236","article-title":"Congenital disorder of glycosylation type Ia (CDG-Ia): Phenotypic spectrum of the R141H\/F119L genotype","volume":"85","author":"Kjaergaard","year":"2001","journal-title":"Arch Dis Child"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/2324709613503316","article-title":"rhIGF-1 therapy for growth failure and IGF-1 deficiency in congenital disorder of glycosylation ia (PMM2 deficiency)","volume":"1","author":"Miller","year":"2013","journal-title":"J Investig Med High Impact Case Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1507\/ENDOCRJ.EJ20-0706","article-title":"Primary ovarian insufficiency in a female with phosphomannomutase-2 gene (PMM2) mutations for congenital disorder of glycosylation","volume":"68","author":"Masunaga","year":"2021","journal-title":"Endocr J"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005323700680","article-title":"Phosphomannomutase deficiency and normal pubertal development","volume":"21","author":"Artigas","year":"1998","journal-title":"J Inherit Metab Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJPN.2008.09.002","article-title":"Long-term evolution of eight Spanish patients with CDG type Ia: Typical and atypical manifestations","volume":"13","author":"P\u00e9rez-Due\u00f1as","year":"2009","journal-title":"Eur J Paediatric Neurology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/J.1651-2227.1995.TB13720.X","article-title":"Gonadal function and glycoprotein hormones in the carbohydrate-deficient glycoprotein (CDG) syndrome","volume":"84","author":"Kristiansson","year":"1995","journal-title":"Acta Paediatr"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2018.00216","article-title":"In Vivo and In Vitro impact of carbohydrate variation on human follicle-stimulating hormone function","volume":"9","author":"Bousfield","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1126\/SCIENCE.2990039","article-title":"A role for glycosylation of the \u03b1 subunit in transduction of biological signal in glycoprotein hormones","volume":"229","author":"Sairam","year":"1985","journal-title":"Sci (1979)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2018.00707","article-title":"Structure-function relationships of the follicle-stimulating hormone receptor","volume":"9","author":"Ulloa-Aguirre","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/MEND.11.5.9927","article-title":"The six N-linked carbohydrates of the lutropin\/choriogonadotropin receptor are not absolutely required for correct folding, cell surface expression, hormone binding, or signal transduction","volume":"11","author":"Davis","year":"1997","journal-title":"Mol Endocrinology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2005.02.005","article-title":"Menon KMJ. N-linked glycosylation facilitates processing and cell surface expression of rat luteinizing hormone receptor","volume":"235","author":"Clouser","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1385\/ENDO:26:3:249","article-title":"Gonadotropin receptors: Role of post-translational modifications and post-transcriptional regulation","volume":"26","author":"Menon","year":"2005","journal-title":"Endocrine"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(94)03449-4","article-title":"Identification of N-glycosylation sites in the gonadotropin-releasing hormone receptor: role in receptor expression but not ligand binding","volume":"107","author":"Davidson","year":"1995","journal-title":"Mol Cell Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/S10815-019-01675-8","article-title":"Novel PMM2 missense mutation in a Chinese family with non-syndromic premature ovarian insufficiency","volume":"37","author":"Peng","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1530\/REP-07-0469","article-title":"Oocyte-specific deletion of complex and hybrid N-glycans leads to defects in preovulatory follicle and cumulus mass development","volume":"137","author":"Williams","year":"2008","journal-title":"Reproduction"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1210\/EN.2010-0917","article-title":"Premature ovarian failure in mice with oocytes lacking core 1-derived O-glycans and complex N-glycans","volume":"152","author":"Williams","year":"2011","journal-title":"Endocrinology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2009.01.003","article-title":"The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia)","volume":"1792","author":"Gr\u00fcnewald","year":"2009","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2016.12.014","article-title":"Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II","volume":"120","author":"Al Teneiji","year":"2017","journal-title":"Mol Genet Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/AJMG.C.30143","article-title":"Clinical features in adults with congenital disorders of glycosylation type Ia (CDG-Ia)","volume":"145","author":"Krasnewich","year":"2007","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2019.00017","article-title":"Hormonal regulation of follicle-stimulating hormone glycosylation in males","volume":"10","author":"Campo","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/J.YMGME.2012.02.001","article-title":"Thyroid function in PMM2-CDG: Diagnostic approach and proposed management","volume":"105","author":"Mohamed","year":"2012","journal-title":"Mol Genet Metab"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/ENDO-118-4-1614","article-title":"The role of glycosylation in the molecular conformation and secretion of thyroxine-binding globulin","volume":"118","author":"Murata","year":"1986","journal-title":"Endocrinology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1210\/JCEM.80.12.8530628","article-title":"Thyroid function tests and characterization of thyroxine-binding globulin in the carbohydrate-deficient glycoprotein syndrome type I","volume":"80","author":"Macchia","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1136\/JMG.38.1.14","article-title":"A broad spectrum of clinical presentations in congenital disorders of glycosylation I: A series of 26 cases","volume":"38","author":"De Lonlay","year":"2001","journal-title":"J Med Genet"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS19092792","article-title":"Glycosylation in the thyroid gland: Vital aspects of glycoprotein function in thyrocyte physiology and thyroid disorders","volume":"19","author":"Zabczy\u0144ska","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.4274\/JCRPE.GALENOS.2022.2021-10-14","article-title":"Hyperinsulinism may be underreported in hypoglycemic patients with phosphomannomutase 2 deficiency","volume":"14","author":"Vurall\u0131","year":"2022","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/JMD2.12085","article-title":"Hypoglycemia in CDG patients due to PMM2 mutations: Follow up on hyperinsulinemic patients","volume":"51","author":"Moravej","year":"2020","journal-title":"JIMD Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1074\/JBC.M203109200","article-title":"Membrane targeting of ATP-sensitive potassium channel: Effects of glycosylation on surface expression","volume":"277","author":"Conti","year":"2002","journal-title":"J Biol Chem"},{"key":"B43","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1210\/ER.2017-00073","article-title":"Insulin receptor isoforms in physiology and disease: An updated view","volume":"38","author":"Belfiore","year":"2017","journal-title":"Endocr Rev"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/S10545-009-1180-2","article-title":"Congenital disorder of glycosylation type Ia: Heterogeneity in the clinical presentation from multivisceral failure to hyperinsulinaemic hypoglycaemia as leading symptoms in three infants with phosphomannomutase deficiency","volume":"32","author":"Shanti","year":"2009","journal-title":"J Inherit Metab Dis"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1023\/A:1013944308881","article-title":"Hyperinsulinaemic hypoglycaemia - Leading symptom in a patient with congenital disorder of glycosylation Ia (phosphomannomutase deficiency)","volume":"24","author":"B\u00f6hles","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/J.YMGME.2021.06.003","article-title":"Should patients with Phosphomannomutase 2-CDG be screened for adrenal insufficiency","volume":"133","author":"\u010cechov\u00e1","year":"2021","journal-title":"Mol Genet Metab"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1152\/AJPENDO.2001.281.5.E1015\/ASSET\/IMAGES\/LARGE\/H11110566005.JPEG","article-title":"Abou-Samra AB. N-glycosylation of CRF receptor type 1 is important for its ligand-specific interaction","volume":"281","author":"Assil","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/GLYCOB\/CWR060","article-title":"N-Glycosylation controls trafficking, zymogen activation and substrate processing of proprotein convertases PC1\/3 and subtilisin kexin isozyme-1","volume":"21","author":"Zandberg","year":"2011","journal-title":"Glycobiology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1210\/EN.2009-0826","article-title":"Role of asparagine-linked glycosylation in cell surface expression and function of the human adrenocorticotropin receptor (melanocortin 2 receptor) in 293\/FRT cells","volume":"151","author":"Roy","year":"2010","journal-title":"Endocrinology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1530\/EC-19-0242","article-title":"N-Glycosylation influences human corticosteroid-binding globulin measurements","volume":"8","author":"Hill","year":"2019","journal-title":"Endocr Connect"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.036484","article-title":"N-glycosylation defects in humans lower low-density lipoprotein cholesterol through increased low-density lipoprotein receptor expression","volume":"140","author":"Van Den Boogert","year":"2019","journal-title":"Circulation"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1136\/JMEDGENET-2019-106102","article-title":"Hypolipidaemia among patients with PMM2-CDG is associated with low circulating PCSK9 levels: A case report followed by observational and experimental studies","volume":"57","author":"Chong","year":"2020","journal-title":"J Med Genet"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1074\/JBC.M606495200","article-title":"The proprotein convertase (PC) PCSK9 is inactivated by furin and\/or PC5\/6A: Functional consequences of natural mutations and post-translational modifications","volume":"281","author":"Benjannet","year":"2006","journal-title":"J Biol Chem"},{"key":"B54","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1203\/00006450-199504000-00003","article-title":"Endocrinology of the carbohydrate-deficient glycoprotein syndrome type 1 from birth through adolescence","volume":"37","author":"De Zegher","year":"1995","journal-title":"Pediatr Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s41436","article-title":"Long-term follow-up in PMM2-CDG: are we ready to start treatment trials","volume":"21","author":"Witters","year":"2019","journal-title":"Genet Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1136\/ADC.87.4.324","article-title":"Prepubertal growth in congenital disorder of glycosylation type Ia (CDG-Ia)","volume":"87","author":"Kjaergaard","year":"2002","journal-title":"Arch Dis Child"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1210\/JC.2008-1502","article-title":"Two short children born small for gestational age with insulin-like growth factor 1 receptor haploinsufficiency illustrate the heterogeneity of its phenotype","volume":"94","author":"Ester","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1210\/JC.2004-1254","article-title":"Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation","volume":"90","author":"Walenkamp","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1210\/ENDO.140.11.7092","article-title":"The mutant growth hormone-releasing hormone (GHRH) receptor of the little mouse does not bind GHRH","volume":"140","author":"Gaylinn","year":"1999","journal-title":"Endocrinology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/S41436-019-0647-2","article-title":"Therapeutic approaches in Congenital Disorders of Glycosylation (CDG) involving N-linked glycosylation: an update","volume":"22","author":"Verheijen","year":"2020","journal-title":"Genet Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90275-9","article-title":"Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure","volume":"82","author":"Aittom\u00e4ki","year":"1995","journal-title":"Cell"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1210\/JCEM.81.10.8855829","article-title":"Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene","volume":"81","author":"Aittom\u00e4ki","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2023.107562","article-title":"Thrombosis risk with estrogen use for puberty induction in congenital disorders of glycosylation","volume":"138","author":"Eklund","year":"2023","journal-title":"Mol Genet Metab"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1007\/S00415-014-7549-7","article-title":"A nationwide survey of PMM2-CDG in Italy: High frequency of a mild neurological variant associated with the L32R mutation","volume":"262","author":"Barone","year":"2015","journal-title":"J Neurol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/NG0297-205","article-title":"Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility","volume":"15","author":"Tapanainen","year":"1997","journal-title":"Nat Genet"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.2337\/DIAB.42.7.966","article-title":"Glycosylation of Asn397 or Asn418 is required for normal insulin receptor biosynthesis and processing","volume":"42","author":"Bastian","year":"1993","journal-title":"Diabetes"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1021\/BI00081A029","article-title":"Specific glycosylation site mutations of the insulin receptor \u03b1 Subunit impair intracellular transport","volume":"32","author":"Collier","year":"1993","journal-title":"Biochemistry"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)32417-1","article-title":"The functions of the human insulin receptor are affected in different ways by mutation of each of the four N-glycosylation sites in the beta subunit","volume":"269","author":"Leconte","year":"1994","journal-title":"J Biol Chem"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/J.YMGME.2013.08.017","article-title":"Abnormal fat distribution in PMM2-CDG","volume":"110","author":"Wolthuis","year":"2013","journal-title":"Mol Genet Metab"},{"key":"B70","first-page":"83","article-title":"Should nifedipine be used to counter low blood sugar levels in children with persistent hyperinsulinaemic hypoglycaemia","volume":"89","author":"M\u00fcller","year":"2004","journal-title":"Arch Dis Child"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016121312","article-title":"Polycystic kidney disease with hyperinsulinemic hypoglycemia caused by a promoter mutation in phosphomannomutase 2","volume":"28","author":"Cabezas","year":"2017","journal-title":"J Am Soc Nephrology"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2022.1102307\/BIBTEX","article-title":"Phosphomannomutase 2 hyperinsulinemia: Recent advances of genetic pathogenesis, diagnosis, and management","volume":"13","author":"Chen","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B73","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4274\/JCRPE.2017.S007","article-title":"Congenital hyperinsulinism: diagnosis and treatment update","volume":"9","author":"Demirbilek","year":"2017","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s13023-025-03669-5","article-title":"A comprehensive update of genotype-phenotype correlations in PMM2-CDG: insights from molecular and structural analyses Orphanet Journal of Rare Diseases","volume":"20","author":"Oliveira","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1186\/S13023-023-02852-W","article-title":"Congenital disorders of glycosylation: narration of a story through its patents","volume":"18","author":"Monticelli","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13023-021-01988-X\/METRICS","article-title":"Mannose supplementation in PMM2-CDG","volume":"16","author":"Taday","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1186\/S13023-021-01751-2","article-title":"Spontaneous improvement of carbohydrate-deficient transferrin in PMM2-CDG without mannose observed in CDG natural history study","volume":"16","author":"Witters","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2024.108487","article-title":"Liposome-encapsulated mannose-1-phosphate therapy improves global N-glycosylation in different congenital disorders of glycosylation","volume":"142","author":"Budhraja","year":"2024","journal-title":"Mol Genet Metab"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1111\/CGE.13088","article-title":"Protein misfolding diseases: Prospects of pharmacological treatment","volume":"93","author":"G\u00e1mez","year":"2018","journal-title":"Clin Genet"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/ANA.25457","article-title":"AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG)","volume":"85","author":"Mart\u00ednez-Monseny","year":"2019","journal-title":"Ann Neurol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/ANA.26245","article-title":"Sorbitol is a severity biomarker for PMM2-CDG with therapeutic implications","volume":"90","author":"Ligezka","year":"2021","journal-title":"Ann Neurol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1594118\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T04:13:39Z","timestamp":1753244019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1594118\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":81,"alternative-id":["10.3389\/fendo.2025.1594118"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1594118","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"article-number":"1594118"}}